Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » More Study Needed on Protein-Cancer Link
Uncategorized

More Study Needed on Protein-Cancer Link

By medwebFeb 1, 2004
Share
Facebook Twitter Email

More Study Needed on Protein-Cancer Link

A preliminary study suggests that persistent inflammation, as indicated by increased levels of C-reactive protein in the blood, is a risk factor for the development of colon cancer.

However, according to an editorial by Feinberg School of Medicine researcher Boris C. Pasche, MD, the link between chronic inflammation and colon cancer must be further explored before C-reactive protein is confirmed as a risk predictor.

The study and editorial appear in the February 4 issue of the Journal of the American Medical Association.

Dr. Pasche, a hematologist/oncologist, is assistant professor of medicine at the medical school and director of cancer genetics at The Robert H. Lurie Comprehensive Cancer Center of Northwestern University. Dr. Pasche’s co-author on the editorial was Charles N. Serhan, PhD, of Brigham and Women’s Hospital and Harvard Medical School, Boston.

C-reactive protein is produced primarily in the liver and is a marker of inflammation. It was discovered about 70 years ago as a marker of infection in patients with pneumonia. Recent studies have shown that increased levels of C-reactive protein may also be predictive of heart attack and other cardiovascular events and may play a role in the development of some forms of cancer, including colon cancer.

Share. Facebook Twitter Email

Related Posts

Lurie Cancer Center Receives Merit Extension from NCI

Oct 20, 2021

Drug Combination May Reduce Risk of Leukemia Relapse

Mar 26, 2020

Rewriting the Role of a Transcription Factor

Mar 19, 2020

Comments are closed.

Latest News

Epigenetic Biomarkers Predict CVD Risk

Jun 28, 2022

Student Spearheads Ukraine Aid Efforts

Jun 27, 2022

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Combination Treatment May Improve Quality of Life in Kidney Cancer

Jun 23, 2022
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20220617_NM_0434
20220617_NM_0858
20220617_NM_0643
20220617_NM_0835
20220617_NM_0544
20220617_NM_0450
20220617_NM_0790
20220617_NM_0811
20220617_NM_0851
20220617_NM_0696
20220617_NM_0779
20220617_NM_0838

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2022 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.